PROM1 and colonic neoplasm: In colon cancer, the reduction in population expressing the AC133 epitope and loss of clonogenicity upon differentiation of CSCs did not correspond to a reduction of CD133 promoter activity or its expression at mRNA or protein level (Kemper et al., 2010).